Skip to content
10-Q

Quarterly Report

PACIRA BIOSCIENCES, INC. PCRX

0001628280-26-028871

← back to feed
Filed
Apr 30, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 29, 2026 39.35M sh
Shares Diluted Q1 2026 · Mar 31, 2026 40.91M sh
Shares Diluted Q1 2026 · Mar 31, 2025 46.53M sh
Stock Repurchased Q1 2026 · Mar 31, 2026 $50.05M
Stock Repurchased Q1 2026 · Mar 31, 2025 $0
Capex Q1 2026 · Mar 31, 2026 $2.72M
Capex Q1 2026 · Mar 31, 2025 $8.55M
Operating Cash Flow Q1 2026 · Mar 31, 2026 $25.68M
Operating Cash Flow Q1 2026 · Mar 31, 2025 $35.46M
Long Term Debt Q1 2026 · Mar 31, 2026 $367.66M
Long Term Debt Q1 2026 · Dec 31, 2025 $372.19M
Short Term Investments Q1 2026 · Mar 31, 2026 $57.87M
Short Term Investments Q1 2026 · Dec 31, 2025 $79.88M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $144.31M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $158.55M
Stockholders Equity Q1 2026 · Mar 31, 2026 $653.89M
Stockholders Equity Q1 2026 · Dec 31, 2025 $693.11M
Stockholders Equity Q1 2026 · Mar 31, 2025 $798.54M
Stockholders Equity Q1 2026 · Dec 31, 2024 $778.35M
Current Liabilities Q1 2026 · Mar 31, 2026 $108.79M
Current Liabilities Q1 2026 · Dec 31, 2025 $120.59M
Total Liabilities Q1 2026 · Mar 31, 2026 $554.64M
Total Liabilities Q1 2026 · Dec 31, 2025 $571.81M
Current Assets Q1 2026 · Mar 31, 2026 $514.96M
Current Assets Q1 2026 · Dec 31, 2025 $547.97M
Total Assets Q1 2026 · Mar 31, 2026 $1.21B
Total Assets Q1 2026 · Dec 31, 2025 $1.26B
Eps Diluted Q1 2026 · Mar 31, 2026 $0.07
Eps Diluted Q1 2026 · Mar 31, 2025 $0.10
Eps Basic Q1 2026 · Mar 31, 2026 $0.07
Eps Basic Q1 2026 · Mar 31, 2025 $0.10
Sga Expense Q1 2026 · Mar 31, 2026 $93.94M
Sga Expense Q1 2026 · Mar 31, 2025 $86.78M
Rd Expense Q1 2026 · Mar 31, 2026 $28.07M
Rd Expense Q1 2026 · Mar 31, 2025 $25.34M
Net Income Q1 2026 · Mar 31, 2026 $2.92M
Net Income Q1 2026 · Mar 31, 2025 $4.81M
Operating Income Q1 2026 · Mar 31, 2026 $6.9M
Operating Income Q1 2026 · Mar 31, 2025 $1.99M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $36.41M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $34.31M
Revenue Q1 2026 · Mar 31, 2026 $177.38M
Revenue Q1 2026 · Mar 31, 2025 $168.92M